NPHS1 and liver dysplastic nodule: Despite prior compelling evidence of nephrin dysregulation in DN and the active role of circulating anti-nephrin autoantibodies leading to podocyte disruption, there is a glaring paucity of data currently relating to the applications of anti-nephrin autoantibodies in DN.